LIFE’S IMPACT ON THE HEART: THE REALITY OF SYMPATHETIC OVERDRIVE
Chairperson: S. Julius (Ann Arbor, MI, USA)
- Sympathetic Overdrive in hypertension. Should we differentiate hypertensive Patients?
B. Egan (Greenville, SC, USA)
- Sympathetic Nervous System and Metabolic Abnormalities (Obesity, Metabolic Syndrome, Diabetes)
G. Grassi (Milan, Italy)
- The Activation of the Sympathetic Nervous System – link to CAD & CHF
E. Erdmann (Köln/Cologne, Germany)
- Beta-Blocker treatment in hypertensive patients. Is there a rationale?
G. Mancia (Milan, Italy)